Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 12-2019 | 06-2019 | 12-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,816 | -5,893 | -2,606 | -5,569 | -5,180 |
| Depreciation Amortization | 92 | 178 | 95 | 7 | 3 |
| Other Working Capital | -1,181 | 340 | 699 | -540 | 1,130 |
| Other Operating Activity | 24,264 | -206 | -458 | -2,378 | 567 |
| Operating Cash Flow | $-4,641 | $-5,581 | $-2,270 | $-8,480 | $-3,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -11 | -8 | -16 | -5 |
| Net Acquisitions | 69 | 0 | N/A | 0 | N/A |
| Other Investing Activity | 39 | -438 | -5,470 | 2,060 | -3,055 |
| Investing Cash Flow | $108 | $-449 | $-5,478 | $2,044 | $-3,060 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 63,157 | 5,233 | 5,329 | 7,788 | 7,970 |
| Financing Cash Flow | $63,157 | $5,233 | $5,329 | $7,788 | $7,970 |
| Exchange Rate Effect | -14 | 19 | 13 | -136 | -10 |
| Beginning Cash Position | 4,385 | 5,163 | 5,163 | 3,947 | 3,940 |
| End Cash Position | 62,995 | 4,385 | 2,757 | 5,163 | 5,360 |
| Net Cash Flow | $58,610 | $-778 | $-2,406 | $1,216 | $1,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,641 | -5,581 | -2,270 | -8,480 | -3,480 |
| Free Cash Flow | -4,641 | -5,581 | -2,270 | -8,480 | -3,480 |